146 related articles for article (PubMed ID: 4258943)
1. [The probenecid test. Evaluation in clinical medicine of cerebral metabolism of serotonin and dopamine].
Véron JP; Mérienne L
Nouv Presse Med; 1972 Feb; 1(8):537-9. PubMed ID: 4258943
[No Abstract] [Full Text] [Related]
2. The probenecid test.
Korczyn AD
J Neural Transm Suppl; 1983; 19():173-83. PubMed ID: 6142088
[TBL] [Abstract][Full Text] [Related]
3. [Central metabolism of dopamine and serotonin. III. Preliminary findings on the relations between dopamine metabolism and purine metabolism in the nervous system].
Campanella G; Orefice G; Carrieri P; Mandarini A; Buscaino GA
Acta Neurol (Napoli); 1976; 31(5):571-9. PubMed ID: 138341
[No Abstract] [Full Text] [Related]
4. Cerebrospinal fluid amine metabolites in affective illness: the probenecid technique.
Goodwin FK; Post RM; Dunner DL; Gordon EK
Am J Psychiatry; 1973 Jan; 130(1):73-9. PubMed ID: 4345466
[No Abstract] [Full Text] [Related]
5. Amine metabolism in the human brain: further evaluation of the probenecid test.
Korf J; Van Praag HM
Brain Res; 1971 Dec; 35(1):221-30. PubMed ID: 5134227
[No Abstract] [Full Text] [Related]
6. Parkinsonism-dementia and amyotrophic lateral sclerosis of Guam. Effect of probenecid on monoamine catabolite levels in cerebrospinal fluid.
Chase RN; Schnur JA; Brody JA; Gordon EK
Arch Neurol; 1971 Jul; 25(1):9-13. PubMed ID: 5146413
[No Abstract] [Full Text] [Related]
7. Cerebral metabolites in cerebrospinal fluid as a biochemical approach to the brain.
Moir AT; Ashcroft GW; Crawford TB; Eccleston D; Guldberg HC
Brain; 1970; 93(2):357-68. PubMed ID: 4912291
[No Abstract] [Full Text] [Related]
8. Dopaminergic nervous transmission in Parkinson's disease.
Rinne UK; Sonninen V; Riekkinen P; Laaksonen H
Med Biol; 1974 Jun; 52(3):208-17. PubMed ID: 4371255
[No Abstract] [Full Text] [Related]
9. Cerebrospinal fluid probenecid studies: a reinterpretation.
Cowdry RW; Ebert MH; van Kammen DP; Post RM; Goodwin FK
Biol Psychiatry; 1983 Nov; 18(11):1287-99. PubMed ID: 6197100
[TBL] [Abstract][Full Text] [Related]
10. Some remarks concerning the possible role of brain monoamines (dopamine, noradrenaline, serotonin) in mental disorders.
Hornykiewicz O
J Psychiatr Res; 1974; 11():249-53. PubMed ID: 4282386
[No Abstract] [Full Text] [Related]
11. On the elimination of 5-hydroxyindoleacetic acid and homovanillic acid from cerebrospinal fluid.
Andersson H; von Essen C; Roos BE
Acta Pharmacol Toxicol (Copenh); 1973; 32(1):129-38. PubMed ID: 4741033
[No Abstract] [Full Text] [Related]
12. The effects of high phenylalanine concentrations on serotonin and catecholamine metabolism in the human brain.
McKean CM
Brain Res; 1972 Dec; 47(2):469-76. PubMed ID: 4642573
[No Abstract] [Full Text] [Related]
13. [Biological study of 2 cases of Gilles de la Tourette's disease].
Yvonneau M
Rev Neurol (Paris); 1972 Jan; 126(1):65-70. PubMed ID: 4508361
[No Abstract] [Full Text] [Related]
14. Retarded depression and the dopamine metabolism.
Korf J; van Praag HM
Psychopharmacologia; 1971; 19(2):199-203. PubMed ID: 5565740
[No Abstract] [Full Text] [Related]
15. Biochemical neuropathology of Parkinson's disease.
Javoy-Agid F; Ruberg M; Taquet H; Bokobza B; Agid Y; Gaspar P; Berger B; N'Guyen-Legros J; Alvarez C; Gray F
Adv Neurol; 1984; 40():189-98. PubMed ID: 6695594
[No Abstract] [Full Text] [Related]
16. Clinical measurements of central dopamine and 5-hydroxytryptamine metabolism: reliability and interpretation of cerebrospinal fluid acid monoamine metabolite measures.
Bowers MB
Neuropharmacology; 1972 Jan; 11(1):101-11. PubMed ID: 5060511
[No Abstract] [Full Text] [Related]
17. 5-Hydroxytrytophan as an antidepressant. The predictive value of the probenecid test.
van Praag HM; Korf J
J Nerv Ment Dis; 1974 May; 158(5):331-7. PubMed ID: 4596091
[No Abstract] [Full Text] [Related]
18. Clinical implications of monoamine oxidase inhibition.
Pare CM
Adv Biochem Psychopharmacol; 1972; 5():441-4. PubMed ID: 5054212
[No Abstract] [Full Text] [Related]
19. Central monoamine metabolism in Parkinson's disease.
Chase TN; Ng LK
Arch Neurol; 1972 Dec; 27(6):486-91. PubMed ID: 5083866
[No Abstract] [Full Text] [Related]
20. The probenecid test in Parkinson's disease.
Lakke JP; Korf J; Hoorntje S; Schut T; van Praag HM
Psychiatr Neurol Neurochir; 1973; 76(2):139-46. PubMed ID: 4700931
[No Abstract] [Full Text] [Related]
[Next] [New Search]
